The insulin inhaler developer has received $20.5m in a round featuring Koch Industries subsidiary Molex Ventures.

Baidu Ventures was among the participants in diagnostics technology developer Sherlock Biosciences' series A round, which has closed at $31m.

Nocion Therapeutics has raised $27m in a Partners Innovation Fund-backed series A round to develop drugs for pain and inflammation.

Shin Nippon Biomedical Laboratories was among the investors in its spinoff, which is working on treatments for acute migraine.

Allianz has provided all the capital for AV8 Ventures' first fund, the VC firm being led by former executives at IBM Ventures and Qualcomm Ventures.

The gene therapy developer's latest round featured a $75m investment from Novartis and was closed as it withdrew its IPO application.

Gilead Sciences, Boehringer Ingelheim and Takeda all recorded exits as immunotherapy developer Hookipa went public, floating at the bottom of its range.

Celgene and Pfizer returned for small molecule drug developer Arrakis Therapeutics' latest round, which included GV and Wuxi AppTec Fund.

The healthcare integration platform has increased its total funding to approximately $47m with the Intermountain Healthcare-backed round.

Each week the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.